A p53 drug response signature identifies prognostic genes in high-risk neuroblastoma.

by Eveline Barbieri, Katleen De Preter, Mario Capasso, Peter Johansson, Tsz-Kwong Man, Zaowen Chen, Paris Stowers, Gian Paolo Tonini, Frank Speleman, Jason M Shohet
Published 2013-01-01